Unlock the Power of Artificial Intelligence in Novel Drug Discovery

No longer just a catch phrase, digital transformation in pharma manufacturing is more critical today than ever before and the industry is getting on board.

Ashland and Oakwood Laboratories will showcase application of Viatel™ bioresorbable polymers and customized chemistry in long-acting injectable (LAI) microsphere formulations.

The boom of virtual and augmented reality in the healthcare and pharmaceutical industries is a major growth area for XR. However, there are still many regulatory challenges to overcome, and there are plenty of questions still to be answered.

Osteosarcoma is the most common type of primary bone cancer affecting adolescents and children attributed to rapid bone growth and turnover with a peak incidence at 18 years old. it is a rare incurable and often fatal disease. The current osteosarcoma treatments include standard chemotherapy, limb salvage surgery or amputation. The 5-year relative survival rate is 70% for localized forms, however, metastasis is present in about one fifth to one-quarter of patients at diagnosis, which then contributes to a 5-year survival rate of around 20%. The survival statistics have remained constant with no advances in treatment options for decades highlighting the need for new therapeutic options.